Dr. Reddy's to Release Q3 FY19 Results on February 1, 2019

Earnings call slated for February 1, 6:30 PM IST / 8:00 AM EST

HYDERABAD, India--()--Dr. Reddy's Laboratories (BSE: 500124, NSE: DRREDDY, NYSE: RDY) will announce results for the quarter ended December 31, 2018 on Friday, February 1, 2019 after the Board Meeting.

Summary of Events

             

Event

   

Date and Time

   

Medium

Release of financial results

   

February 1st, after the Board Meeting

   

Email, Media, Company website, Business wire

Press meet presentation

   

Will be available on the Company’s website

   

URL available on Company’s website, www.drreddys.com

Earnings Call

   

February 1st, 6:30 PM IST / 8:00 AM EST

   

Hosted by the Company

(Details below)

Playback of Earnings Call

   

After the earnings call till February 7th

   

Details below

Transcript of the Earnings call

   

Will be available on the Company’s website

   

URL available on Company’s website, www.drreddys.com

       

Earnings Call

Following the release, the management of the Company will host an earnings call to discuss the Company’s financial performance. (Dial In and other details given below)

Play Back

The play back will be available after the earnings call, through February 7th, 2019. For play back dial in phone No: 022 7194 5757 / 022 6663 5757, and Playback Code is 37176.

 

Conference Dial-In Numbers

Universal Access Number:

   

+91 22 6280 1219

+91 22 7115 8120

Local Access Number:

Available all over India

   

+91 70456 71221

International Toll Free Number:

   

USA: 1 866 746 2133

UK: 0 808 101 1573

Singapore: 800 101 2045

Hong Kong: 800 964 448

   

No password/pin number is necessary to dial in to any of the above numbers. The operator will provide instructions on asking questions before and during the call.

About Dr. Reddy’s: Dr. Reddy’s Laboratories Ltd. (BSE: 500124, NSE: DRREDDY, NYSE: RDY) is an integrated pharmaceutical company, committed to providing affordable and innovative medicines for healthier lives. Through its three businesses - Pharmaceutical Services & Active Ingredients, Global Generics and Proprietary Products – Dr. Reddy’s offers a portfolio of products and services including APIs, custom pharmaceutical services, generics, biosimilars and differentiated formulations. Our major therapeutic areas of focus are gastrointestinal, cardiovascular, diabetology, oncology, pain management and dermatology. Dr Reddy’s operates in markets across the globe. Our Major markets include – USA, India, Russia & CIS countries, and Europe. For more information, log on to: www.drreddys.com

Disclaimer: This press release may include statements of future expectations and other forward-looking statements that are based on the management’s current views and assumptions and involve known or unknown risks and uncertainties that could cause actual results, performance or events to differ materially from those expressed or implied in such statements. In addition to statements which are forward-looking by reason of context, the words "may", "will", "should", "expects", "plans", "intends", "anticipates", "believes", "estimates", "predicts", "potential", or "continue" and similar expressions identify forward-looking statements. Actual results, performance or events may differ materially from those in such statements due to without limitation, (i) general economic conditions such as performance of financial markets, credit defaults , currency exchange rates , interest rates , persistency levels and frequency / severity of insured loss events (ii) mortality and morbidity levels and trends, (iii) changing levels of competition and general competitive factors, (iv) changes in laws and regulations and in the policies of central banks and/or governments, (v) the impact of acquisitions or reorganization , including related integration issues.

The company assumes no obligation to update any information contained herein.

Contacts

INVESTOR RELATIONS
AMIT AGARWAL
(Ph: +91-40-49002135)
amita@drreddys.com

MEDIA RELATIONS
CALVIN PRINTER
(Ph: +91-40-49002121)
calvinprinter@drreddys.com

Contacts

INVESTOR RELATIONS
AMIT AGARWAL
(Ph: +91-40-49002135)
amita@drreddys.com

MEDIA RELATIONS
CALVIN PRINTER
(Ph: +91-40-49002121)
calvinprinter@drreddys.com